Triple negative breast cancer.

@article{Cetin2014TripleNB,
  title={Triple negative breast cancer.},
  author={Idil Cetin and Mehmet R Topçul},
  journal={Asian Pacific journal of cancer prevention : APJCP},
  year={2014},
  volume={15 6},
  pages={
          2427-31
        }
}
Triple-negative breast cancers (TNBC), characterized by absence of the estrogen receptor (ER) and progesterone receptor (PR) and lack of overexpression of human epidermal growth factor receptor 2 (HER2), have a poor prognosis. To overcome therapy limitations of TNBC, various new approaches are needed. This mini-review focuses on discovery of new targets and drugs which might offer new hope for TNBC patients. 

Topics from this paper.

Citations

Publications citing this paper.
SHOWING 1-10 OF 10 CITATIONS

Comprehensive analysis of coexpressed long noncoding RNAs and genes in breast cancer.

  • The journal of obstetrics and gynaecology research
  • 2019
VIEW 1 EXCERPT
CITES BACKGROUND

Effects of metformin on cell kinetic parameters of MCF-7 breast cancer cells in vitro.

  • Asian Pacific journal of cancer prevention : APJCP
  • 2015
VIEW 1 EXCERPT
CITES BACKGROUND

References

Publications referenced by this paper.
SHOWING 1-10 OF 74 REFERENCES

Pharmacodynamic and pathway analysis of three presumed inhibitors of poly ( ADP - ribose ) polymerase : ABT - 888 , AZD 2281 , and BSI 201 [ abstract ]

S Khokher, MU Qureshi, S Mahmood, AH Nagi
  • 2013
VIEW 1 EXCERPT

Cancer stem cells in oncology.

  • Journal of B.U.ON. : official journal of the Balkan Union of Oncology
  • 2012
VIEW 1 EXCERPT

Inhibiting angiogenesis in breast cancer: the beginning of the end or the end of the beginning?

  • Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • 2012
VIEW 2 EXCERPTS

Targeting cancer stem cells: a new therapy to cure cancer patients.

  • American journal of cancer research
  • 2012
VIEW 2 EXCERPTS